Cost-effectiveness of using hepatitis C viremic hearts for transplantation into HCV-negative recipients

Executive Summary: Heart Disease and Stroke Statistics—2016 Update

Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go et al. · Circulation · 2016 · 2.5K citations

Public Health, Cardiology, Chronic Disease Control +13

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

Peter J. Neumann, Joshua T. Cohen, Milton C. Weinstein · New England Journal of Medicine · 2014 · 2.3K citations

Pharmacy, Health Policy, Pharmacoeconomics +17

United States Life Tables, 2017.

PubMed · 2019 · 805 citations

Social Sciences, Demography, Population Health Sciences +17

Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients

James K. Kirklin, David C. Naftel, Robert L. Kormos et al. · The Journal of Heart and Lung Transplantation · 2013 · 714 citations · Full text

Medicine, Surgery, Cardiothoracic Surgery +9

The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report—2011

Jason D. Christie, Leah B. Edwards, Anna Y. Kucheryavaya et al. · The Journal of Heart and Lung Transplantation · 2011 · 438 citations · Full text

Medicine, Cardiology, Surgery +15